{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:56:51Z","timestamp":1790704611101,"version":"4.1.0"},"reference-count":71,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br. J. Hosp. Med. (Lond)"],"abstract":"<jats:p>Primary hyperparathyroidism (PHPT) is the most common parathyroid disease and one of the most common endocrine disorders. It results from autonomous overproduction of parathyroid hormone, which in the classic form of the disease causes hypercalcaemia. The ready access to biochemical testing in high-income countries has moved the disease spectrum from a classic symptomatic presentation to a biochemical anomaly that is asymptomatic or minimally symptomatic. Untreated PHPT, however, remains associated with significant consequences. This review summarizes up-to-date concepts in the diagnosis, imaging, and surgical management of PHPT. The diagnosis of PHPT requires confirmation of hypercalcaemia with inappropriately elevated or unsuppressed parathyroid hormone levels, while excluding alternative causes. Parathyroidectomy remains the only definitive cure for PHPT, and the changing thresholds for intervention are discussed. Advances in pre-operative localization, including high-resolution ultrasonography, 99mTc-sestamibi (technetium-99m methoxyisobutylisonitrile), 4D-computed tomography, and fluorocholine positron emission tomography, have increased the number of patients with localised disease and therefore facilitated focused and minimally invasive surgical approaches. Intraoperative parathyroid hormone monitoring has also added a new dimension to intraoperative decision-making. However, the single biggest determinant of outcome in parathyroidectomy remains the practice volume and experience of the operating surgeon. It remains to be seen whether emerging technologies, including robotic surgery, thermal ablation, advanced molecular imaging, and artificial intelligence\u2013assisted diagnosis and lesion localization, will further refine patient selection and improve treatment strategies in PHPT.<\/jats:p>","DOI":"10.31083\/bjhm57924","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:59:52Z","timestamp":1790701192000},"source":"Crossref","is-referenced-by-count":0,"title":["Parathyroid Surgery for Primary Hyperparathyroidism in 2026"],"prefix":"10.31083","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2307-3192","authenticated-orcid":true,"given":"Shawn","family":"Thomas","sequence":"first","affiliation":[{"name":"Department of Endocrine & Thyroid Surgery, Hammersmith Hospital, Imperial College Healthcare NHS Trust, W12 0HS London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4999-9348","authenticated-orcid":true,"given":"Fausto F","family":"Palazzo","sequence":"additional","affiliation":[{"name":"Department of Endocrine & Thyroid Surgery, Hammersmith Hospital, Imperial College Healthcare NHS Trust, W12 0HS London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Wade TJ, Yen TWF, Amin AL, Wang TS. Surgical management of normocalcemic primary hyperparathyroidism. World Journal of Surgery. 2012; 36: 761\u2013766.","DOI":"10.1007\/s00268-012-1438-y"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Gawrychowski J, Kowalski GJ, Bu\u0142a G, Bednarczyk A, \u017b\u0105d\u0142o D, Niedzielski Z, et al. Surgical Management of Primary Hyperparathyroidism-Clinicopathologic Study of 1019 Cases from a Single Institution. Journal of Clinical Medicine. 2020; 9: 3540.","DOI":"10.3390\/jcm9113540"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Islam AK. Advances in the diagnosis and the management of primary hyperparathyroidism. Therapeutic Advances in Chronic Disease. 2021; 12: 20406223211015965.","DOI":"10.1177\/20406223211015965"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Lundgren E, Hagstr\u00f6m EG, Lundin J, Winnerb\u00e4ck K, Roos J, Ljunghall S, et al. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World Journal of Surgery. 2002; 26: 931\u2013936.","DOI":"10.1007\/s00268-002-6621-0"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GEH, Marcocci C, Minisola S, et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. Journal of Bone and Mineral Research. 2022; 37: 2293\u20132314.","DOI":"10.1002\/jbmr.4677"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Malberti F, Farina M, Imbasciati E. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism. Nephrology, Dialysis, Transplantation. 1999; 14: 2398\u20132406.","DOI":"10.1093\/ndt\/14.10.2398"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Iwanowska M, Kochman M, Szatko A, Zgliczy\u0144ski W, Glinicki P. Bone Disease in Primary Hyperparathyroidism-Changes Occurring in Bone Metabolism and New Potential Treatment Strategies. International Journal of Molecular Sciences. 2024; 25: 11639.","DOI":"10.3390\/ijms252111639"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Kurtom S, Carty SE. Primary Hyperparathyroidism: Part Two: Surgical Management. The Surgical Clinics of North America. 2024; 104: 799\u2013809.","DOI":"10.1016\/j.suc.2024.02.009"},{"key":"ref9","unstructured":"Walker MD, Bilezikian JP. Primary hyperparathyroidism. MDText.com, Inc.: South Dartmouth (MA). 2021."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"McAllister J, Arshad MF, Rab E, Balasubramanian SP. Excluding familial hypocalciuric hypercalcaemia before surgery for primary hyperparathyroidism - a practical evaluation of urinary calcium using a retrospective cohort design. Annals of the Royal College of Surgeons of England. 2022; 104: 710\u2013716.","DOI":"10.1308\/rcsann.2021.0333"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nature Reviews. Endocrinology. 2018; 14: 115\u2013125.","DOI":"10.1038\/nrendo.2017.104"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Kochman M. Primary hyperparathyroidism: clinical manifestations, diagnosis and evaluation according to the Fifth International Workshop guidelines. Reumatologia. 2023; 61: 256\u2013263.","DOI":"10.5114\/reum\/170705"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Balachandra S, Wang R, Akhund R, Allahwasaya A, Lindeman B, Fazendin J, et al. Patients with normocalcemic versus hypercalcemic hyperparathyroidism: What's really the difference? American Journal of Surgery. 2025; 244: 116272.","DOI":"10.1016\/j.amjsurg.2025.116272"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Dawood NB, Tseng CH, Nguyen DT, Yan KL, Livhits MJ, Leung AM, et al. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment. The Journal of Clinical Endocrinology and Metabolism. 2021; 106: e4993\u2013e5000.","DOI":"10.1210\/clinem\/dgab540"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"O\u2019Brien JP, Romero-Velez G, Noureldine SI, Burneikis T, Sehnem L, Siperstein A. Development of a machine learning model for the diagnosis of atypical primary hyperparathyroidism. Endocrine and Metabolic Science. 2024; 15: 100170.","DOI":"10.1016\/j.endmts.2024.100170"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Vescini F, Borretta G, Chiodini I, Boniardi M, Carotti M, Castellano E, et al. Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism. Endocrine, Metabolic & Immune Disorders Drug Targets. 2024; 24: 991\u20131006.","DOI":"10.2174\/0118715303260423231122111705"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Swaminathan N, Kasmirski JA, Gillis A, Lindeman B, Dream S, Chen H. From genes to glands: The genetic framework of parathyroid syndromes. Surgical Oncology Insight. 2025; 2: 100143.","DOI":"10.1016\/j.soi.2025.100143"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Mazarico-Altisent I, Capel I, Baena N, Bella-Cueto MR, Barcons S, Guirao X, et al. Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort. Frontiers in Endocrinology. 2023; 14: 1244361.","DOI":"10.3389\/fendo.2023.1244361"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Grover A, Jha S. Heritable hyperparathyroidism: Genetic insights and clinical implications. Best Practice & Research. Clinical Endocrinology & Metabolism. 2025; 39: 101984.","DOI":"10.1016\/j.beem.2025.101984"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Albright F. A page out of the history of hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 1948; 8: 637\u2013657.","DOI":"10.1210\/jcem-8-8-637"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Silverberg SJ, Walker MD, Bilezikian JP. Asymptomatic primary hyperparathyroidism. Journal of Clinical Densitometry. 2013; 16: 14\u201321.","DOI":"10.1016\/j.jocd.2012.11.005"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Insogna KL. Primary Hyperparathyroidism. The New England Journal of Medicine. 2018; 379: 1050\u20131059.","DOI":"10.1056\/NEJMcp1714213"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Arya AK, Kumari P, Bhadada SK, Agrawal K, Singh P, Mukherjee S, et al. Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry. Journal of Bone and Mineral Metabolism. 2021; 39: 253\u2013259.","DOI":"10.1007\/s00774-020-01142-w"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Sadacharan D, Mathews MZ, Sathya A, Gopal S, Chandrasekaran S, Murthy S, et al. Primary Hyperparathyroidism: Clinical, Biochemical, and Radio-Pathological Profiles of 804 Patients - A Retrospective Study from South India. Indian Journal of Endocrinology and Metabolism. 2025; 29: 69\u201376.","DOI":"10.4103\/ijem.ijem_468_24"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Chen Y, Wang J, Li S, Zhao Q, Wang K, Liu M. Trends in Clinical Features of Primary Hyperparathyroidism During 2013-2024. International Journal of Endocrinology. 2026; 2026: 9936658.","DOI":"10.1155\/ije\/9936658"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Kim KJ, Baek S, Yu MH, Shin S, Cho S, Rhee Y, et al. Secular trends in the incidence and treatment patterns of primary hyperparathyroidism in Korea: a nationwide cohort study. JBMR Plus. 2024; 8: ziae065.","DOI":"10.1093\/jbmrpl\/ziae065"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Garg S, Pal R, Bhadada SK. Rising Trend in the Frequency of Secondary and Tertiary Hyperparathyroidism: Observations from the Indian PHPT Registry. Indian Journal of Endocrinology and Metabolism. 2024; 28: 659.","DOI":"10.4103\/ijem.ijem_376_24"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Mollerup CL, Vestergaard P, Fr\u00f8kjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ (Clinical Research Ed.). 2002; 325: 807.","DOI":"10.1136\/bmj.325.7368.807"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Marchini GS, Faria KVM, Torricelli FCM, Monga M, Srougi M, Nahas WC, et al. Sporadic primary hyperparathyroidism and stone disease: a comprehensive metabolic evaluation before and after parathyroidectomy. BJU International. 2018; 121: 281\u2013288.","DOI":"10.1111\/bju.14072"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surgery. 2016; 151: 959\u2013968.","DOI":"10.1001\/jamasurg.2016.2310"},{"key":"ref31","unstructured":"Hyperparathyroidism (primary): diagnosis, assessment and initial management. National Institute for Health and Care Excellence (NICE): London. 2019."},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Bollerslev J, Cetani F, Gittoes N, Rolighed L. Individualized management of primary hyperparathyroidism. Journal of Internal Medicine. 2026; 299: 650\u2013669.","DOI":"10.1111\/joim.70089"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Spartalis ED, Kouriannidi E, Athanasiadis DI, Chrysikos DT, Makay \u00d6, Troupis T. Edward D. Churchill (1895-1972): An Innovative Surgeon, His Work, and His Contribution to Parathyroid Surgery. Surgical Innovation. 2021; 28: 159\u2013162.","DOI":"10.1177\/1553350620950908"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Morris MA, Saboury B, Ahlman M, Malayeri AA, Jones EC, Chen CC, et al. Parathyroid Imaging: Past, Present, and Future. Frontiers in Endocrinology. 2022; 12: 760419.","DOI":"10.3389\/fendo.2021.760419"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Khan ZF, Lew JI. Intraoperative Parathyroid Hormone Monitoring in the Surgical Management of Sporadic Primary Hyperparathyroidism. Endocrinology and Metabolism. 2019; 34: 327\u2013339.","DOI":"10.3803\/EnM.2019.34.4.327"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Carrillo Lizarazo JL, Cecchin D, Camozzi V, Crim\u00ec F, Torresan F, Iacobone M. Impact of 18F-choline PET-CT or PET-MRI on surgical strategy in patients with primary hyperparathyroidism. BJS Open. 2025; 9: zraf069.","DOI":"10.1093\/bjsopen\/zraf069"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Singhal A. Optimum Imaging for Parathyroid Localization in Primary Hyperparathyroidism. Journal of Head & Neck Physicians and Surgeons. 2023; 11: 71\u201373.","DOI":"10.4103\/jhnps.jhnps_64_23"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Pavlidis ET, Pavlidis TE. Update on the current management of persistent and recurrent primary hyperparathyroidism after parathyroidectomy. World Journal of Clinical Cases. 2023; 11: 2213\u20132225.","DOI":"10.12998\/wjcc.v11.i10.2213"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Fries F, Thaeren J, Greschus S, Muschler E, Palmedo H, Loriz HL, et al. Preoperative imaging strategies to optimize surgical treatment in primary hyperparathyroidism (pHPT). BMC Surgery. 2026; 26: 340.","DOI":"10.1186\/s12893-026-03768-5"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Altintop SE, Cerit MN, Cindil E, Sendur HN, Barlas T, Yalcin MM, et al. Dynamic 4 dimensional contrast enhanced MRI for localization in primary hyperparathyroidism. Endocrine. 2025; 89: 267\u2013275.","DOI":"10.1007\/s12020-025-04239-2"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Quak E, Lasne-Cardon A, Cavarec M, Lireux B, Bastit V, Roudaut N, et al. F18-Choline PET\/CT or MIBI SPECT\/CT in the Surgical Management of Primary Hyperparathyroidism: A Diagnostic Randomized Clinical Trial. JAMA Otolaryngology\u2013Head & Neck Surgery. 2024; 150: 658\u2013665.","DOI":"10.1001\/jamaoto.2024.1421"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Kang S, Cho H, Kim E, Kim JK, Kang SW, Jeong JJ, et al. Comparison of 18F-Choline PET\/CT and 99mTc-Sestamibi SPECT\/CT in the Localization of Hyperactive Parathyroid Glands in Primary Hyperparathyroidism: Diagnostic Performance in Discordant Cases. Frontiers in Endocrinology. 2025; 16: 1677278.","DOI":"10.3389\/fendo.2025.1677278"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"das Neves MC, Santos RO, Ohe MN. Surgery for primary hyperparathyroidism. Archives of Endocrinology and Metabolism. 2022; 66: 678\u2013688.","DOI":"10.20945\/2359-3997000000557"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Jarabek L, Jamsek J, Cuderman A, Rep S, Hocevar M, Kocjan T, et al. Detection and localization of hyperfunctioning parathyroid glands on [18F]fluorocholine PET\/ CT using deep learning - model performance and comparison to human experts. Radiology and Oncology. 2022; 56: 440\u2013452.","DOI":"10.2478\/raon-2022-0037"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Apostolopoulos ID, Papandrianos NI, Papageorgiou EI, Apostolopoulos DJ. Artificial Intelligence Methods for Identifying and Localizing Abnormal Parathyroid Glands: A Review Study. Machine Learning and Knowledge Extraction. 2022; 4: 814\u2013826.","DOI":"10.3390\/make4040040"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Chander NR, Chidambaram S, Van Den Heede K, DiMarco AN, Tolley NS, Palazzo FF. Correlation of Preoperative Imaging Findings and Parathyroidectomy Outcomes Support NICE 2019 Guidance. The Journal of Clinical Endocrinology and Metabolism. 2022; 107: e1242\u2013e1248.","DOI":"10.1210\/clinem\/dgab740"},{"key":"ref47","unstructured":"Nanoo P, Silva PS, Babu M. Safety, efficacy and advantages of day-case minimally invasive parathyroidectomy for localised parathyroid adenomas: a systematic review and evidence synthesis. Journal of Otolaryngology-ENT Research. 2026; 18: 10\u201312."},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Sen S, Cherian AJ, Ramakant P, Reka K, Paul MJ, Abraham DT. Focused Parathyroidectomy Under Local Anesthesia - A Feasibility Study. Indian Journal of Endocrinology and Metabolism. 2019; 23: 67\u201371.","DOI":"10.4103\/ijem.IJEM_590_18"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Mazotas IG, Yen TWF, Doffek K, Shaker JL, Carr AA, Evans DB, et al. Persistent\/Recurrent Primary Hyperparathyroidism: Does the Number of Abnormal Glands Play a Role? The Journal of Surgical Research. 2020; 246: 335\u2013341.","DOI":"10.1016\/j.jss.2019.08.007"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Wang TS, Ostrower ST, Heller KS. Persistently elevated parathyroid hormone levels after parathyroid surgery. Surgery. 2005; 138: 1130\u20131135; discussion 1135\u20131136.","DOI":"10.1016\/j.surg.2005.08.026"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Solorzano CC, Mendez W, Lew JI, Rodgers SE, Montano R, Carneiro-Pla DM, et al. Long-term outcome of patients with elevated parathyroid hormone levels after successful parathyroidectomy for sporadic primary hyperparathyroidism. Archives of Surgery. 2008; 143: 659\u2013663; discussion 663.","DOI":"10.1001\/archsurg.143.7.659"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Henry JF. Minimally invasive thyroid and parathyroid surgery is not a question of length of the incision. Langenbeck's Archives of Surgery. 2008; 393: 621\u2013626.","DOI":"10.1007\/s00423-008-0406-3"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Miccoli P, Berti P, Materazzi G, Donatini G. Minimally invasive video assisted parathyroidectomy (MIVAP). European Journal of Surgical Oncology. 2003; 29: 188\u2013190.","DOI":"10.1053\/ejso.2002.1313"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Kandil E, Hadedeya D, Shalaby M, Toraih E, Apar\u00edcio D, Garstka M, et al. Robotic-assisted parathyroidectomy via transaxillary approach: feasibility and learning curves. Gland Surgery. 2021; 10: 953\u2013960.","DOI":"10.21037\/gs-20-761"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Russell JO, Sahli ZT, Shaear M, Razavi C, Ali K, Tufano RP. Transoral thyroid and parathyroid surgery via the vestibular approach-a 2020 update. Gland Surgery. 2020; 9: 409\u2013416.","DOI":"10.21037\/gs.2020.03.05"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Lin XJ, Han P, Chen RH, Lin PL, Wang JY, Kong XW, et al. Robotic-Assisted Transaxillary Parathyroidectomy: A Safe and Cosmetically Alternative for Primary Hyperparathyroidism. World Journal of Otorhinolaryngology - Head and Neck Surgery. 2025; 12: 346\u2013352.","DOI":"10.1002\/wjo2.70064"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Khanom S, Singh K, Blinkhorn LS, Ravendran K. Robotic Resection of an Ectopic Parathyroid Gland: A Systematic Review. Cureus. 2024; 16: e75096.","DOI":"10.7759\/cureus.75096"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Park D, Cho H, Lee E, Oh MY, Kim K, Chai YJ, et al. Feasibility and Safety of transoral robotic parathyroidectomy: Initial experience with a new approach for parathyroid surgery. Asian Journal of Surgery. 2024; 47: 4300\u20134306.","DOI":"10.1016\/j.asjsur.2024.07.162"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Parnell KE, Oltmann SC. The Surgical Management of Primary Hyperparathyroidism: An Updated Review. International Journal of Endocrine Oncology. 2018; 5: IJE07.","DOI":"10.2217\/ije-2017-0019"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Iacobone M, Scerrino G, Palazzo FF. Parathyroid surgery: an evidence-based volume\u2014outcomes analysis: European Society of Endocrine Surgeons (ESES) positional statement. Langenbeck's Archives of Surgery. 2019; 404: 919\u2013927.","DOI":"10.1007\/s00423-019-01823-9"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Annals of Surgery. 2000; 231: 732\u2013742.","DOI":"10.1097\/00000658-200005000-00014"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Santos PM, Fernandes ML, Barbosa AP. The Application of Radiofrequency Ablation on Primary Hyperparathyroidism: A Scoping Review. Endocrinology Insights. 2025; 20: 197\u2013209.","DOI":"10.1159\/000548739"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Cui HY, Bai XM, Yang H, He Y. Comparison of thermal ablation and surgery for hyperparathyroidism: a meta-analysis. International Journal of Hyperthermia. 2025; 42: 2441402.","DOI":"10.1080\/02656736.2024.2441402"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Wei Y, Peng CZ, Wang SR, He JF, Peng LL, Zhao ZL, et al. Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study. The Journal of Clinical Endocrinology and Metabolism. 2021; 106: 2707\u20132717.","DOI":"10.1210\/clinem\/dgab240"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL 3rd. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery. 2003; 134: 973\u2013979.","DOI":"10.1016\/j.surg.2003.06.001"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Bollerslev J, Rejnmark L, Zahn A, Heck A, Appelman-Dijkstra NM, Cardoso L, et al. European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). European Journal of Endocrinology. 2022; 186: R33\u2013R63.","DOI":"10.1530\/EJE-21-1044"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Barraud S, Lopez AG, Sokol E, Menegaux F, Briet C. Chapter 14: Post surgical follow-up of primary hyperparathyroidism. Annales D'endocrinologie. 2025; 86: 101703.","DOI":"10.1016\/j.ando.2025.101703"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Ishii H, Mihai R, Watkinson JC, Kim DS. Systematic review of cure and recurrence rates following minimally invasive parathyroidectomy. BJS Open. 2018; 2: 364\u2013370.","DOI":"10.1002\/bjs5.77"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, Espinosa de Ycaza AE, Jasim S, Castaneda-Guarderas A, et al. Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. World Journal of Surgery. 2016; 40: 2359\u20132377.","DOI":"10.1007\/s00268-016-3514-1"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Ayuk J, Cooper MS, Gittoes NJL. New perspectives in the management of primary hyperparathyroidism. Therapeutic Advances in Endocrinology and Metabolism. 2010; 1: 197\u2013205.","DOI":"10.1177\/2042018810382326"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Zhu X, Zhang Q, Wang L, Xu S, Gong E, Zhou B, et al. Precision stratified treatment of primary hyperparathyroidism based on multilevel emerging biomarkers. Frontiers in Endocrinology. 2025; 16: 1688399.","DOI":"10.3389\/fendo.2025.1688399"}],"container-title":["British Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/9\/10.31083\/BJHM57924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:01:04Z","timestamp":1790701264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/BJHM\/87\/9\/10.31083\/BJHM57924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1759-7390(26)03910-0"],"URL":"https:\/\/doi.org\/10.31083\/bjhm57924","relation":{},"ISSN":["1750-8460","1759-7390"],"issn-type":[{"value":"1750-8460","type":"print"},{"value":"1759-7390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"57924"}}